The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed by the deferral must be used to prepare a full Regulation Impact Statement on the proposal to reschedule codeine. Demarte says the PSA in its
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.